144 results on '"Häfner, Norman"'
Search Results
2. Validation and functional follow‐up of cervical cancer risk variants at the HLA locus.
3. CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients
4. Association of two genomic variants with HPV type-specific risk of cervical cancer
5. The non-canonical inflammasome activators Caspase-4 and Caspase-5 are differentially regulated during immunosuppression-associated organ damage.
6. Association of two genomic variants with HPV subtype-specific risk of cervical cancer
7. Synthesis, Characterization and Biological Investigation of the Platinum(IV) Tolfenamato Prodrug–Resolving Cisplatin-Resistance in Ovarian Carcinoma Cell Lines
8. Novel Homoleptic and Heteroleptic Pt(II) β‐oxodithiocinnamic ester Complexes: Synthesis, Characterization, Interactions with 9‐methylguanine and Antiproliferative Activity
9. Platinum(II) and palladium(II) complexes mediated byβ-hydroxy-dithioesters ferrocenyl derivatives: synthesis, characterization and antiproliferative activity
10. 2022-RA-1104-ESGO Eight years survivors of advanced ovarian cancer
11. Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer
12. Platinum(II) and palladium(II) complexes mediated by β-hydroxy-dithioesters ferrocenyl derivatives: synthesis, characterization and antiproliferative activity.
13. Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with O,S Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues
14. Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms
15. Hypermethylated DAPK in serum DNA of women with uterine leiomyoma is a biomarker not restricted to cancer
16. Synthesis and characterization of thiocarbonato-linked platinum(iv) complexes
17. RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer
18. p53-autoantibody may be more sensitive than CA-125 in monitoring microscopic and macroscopic residual disease after primary therapy for epithelial ovarian cancer
19. Additional file 1 of CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients
20. Novel splice variant CAR 4/6 of the coxsackie adenovirus receptor is differentially expressed in cervical carcinogenesis
21. Evidence for disseminated tumor cells in lymphatic vessels afferent to sentinel lymph nodes in patients diagnosed with cervical cancer
22. RUNX3 Transcript Variants Have Distinct Roles in Ovarian Carcinoma and Differently Influence Platinum Sensitivity and Angiogenesis
23. High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells
24. Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with O , S Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues.
25. An integrative functional genomic and gene expression approach revealed SORBS2 as a putative tumour suppressor gene involved in cervical carcinogenesis
26. BRCA1Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis
27. HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR
28. Differences in Stability of Viral and Viral-Cellular Fusion Transcripts in HPV-Induced Cervical Cancers
29. Abstract GMM-028: VALIDATION OF RUNX3 AND CAMKIINα HYPERMETHYLATION AS PROGNOSTIC MARKER FOR OVARIAN CARCINOMA
30. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands
31. Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer
32. The p38-MK2/3 Module Is Critical for IL-33–Induced Signaling and Cytokine Production in Dendritic Cells
33. Functional Analyses of RUNX3 and CaMKIINα in Ovarian Cancer Cell Lines Reveal Tumor-Suppressive Functions for CaMKIINα and Dichotomous Roles for RUNX3 Transcript Variants
34. A comparative study of digital PCR and real-time qPCR for the detection and quantification of HPV mRNA in sentinel lymph nodes of cervical cancer patients
35. Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA
36. MK2/3 Are Pivotal for IL-33–Induced and Mast Cell–Dependent Leukocyte Recruitment and the Resulting Skin Inflammation
37. Asparagusic acid derivatives and their cytotoxic platinum(II) complexes
38. Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance
39. Unusual mode of protein binding by a cytotoxic π-arene ruthenium(ii) piano-stool compound containing an O,S-chelating ligand
40. TAK1 and IKK2, novel mediators of SCF-induced signaling and potential targets for c-Kit-driven diseases
41. RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer
42. Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status
43. Subthreshold IKK activation modulates the effector functions of primary mast cells and allows specific targeting of transformed mast cells
44. Asparagusic acid derivatives and their cytotoxic platinum(II) complexes.
45. Identification of CAR As a Novel Mediator of Erythroid Differentiation and Migration That Is Specifically Downregulated in Erythropoietic Progenitor Cells in Patients with MDS
46. Digital-Direct-RT-PCR: a sensitive and specific method for quantification of CTC in patients with cervical carcinoma
47. High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL‐ and cisplatin‐induced apoptosis in human ovarian cancer cells
48. Loss of BRCA1 Protein Expression as Indicator of the BRCAness Phenotype Is Associated With Favorable Overall Survival After Complete Resection of Sporadic Ovarian Cancer
49. Differences in Stability of Viral and Viral-Cellular Fusion Transcripts in HPV-Induced Cervical Cancers.
50. Unusual mode of protein binding by a cytotoxic π-arene ruthenium(<scp>ii</scp>) piano-stool compound containing an O,S-chelating ligand
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.